Liu CX - Search Results

1

Methionine restriction promotes cisplatin sensitivity of gastric cancer resistant cells by down-regulating circ-CDK13 level.

Xin L, Zou YH, Liu CX, Lu H, Fan LJ, Xu HS, Zhou Q, Liu J, Yue ZQ, Gan JH. Xin L, et al. Among authors: liu cx. Exp Cell Res. 2024 Oct 31;443(1):114315. doi: 10.1016/j.yexcr.2024.114315. Online ahead of print. Exp Cell Res. 2024. PMID: 39488295

2

KLF10/CBS increases the sensitivity of gastric carcinoma cells to methionine restriction by promoting sulfur transfer pathway.

Xin L, Liu ZY, Liu CX, Sheng J, Zhou Q, Yuan YW, Yue ZQ, Lu H, Gan JH. Xin L, et al. Among authors: liu cx, liu zy. Exp Cell Res. 2024 Apr 1;437(1):114007. doi: 10.1016/j.yexcr.2024.114007. Epub 2024 Mar 16. Exp Cell Res. 2024. PMID: 38499142

3

Methionine restriction attenuates the migration and invasion of gastric cancer cells by inhibiting nuclear p65 translocation through TRIM47.

Xin L, Yuan YW, Liu CX, Sheng J, Zhou Q, Liu ZY, Yue ZQ, Zeng F. Xin L, et al. Among authors: liu cx, liu zy. Biol Chem. 2023 Nov 10;405(4):257-265. doi: 10.1515/hsz-2023-0292. Print 2024 Apr 25. Biol Chem. 2023. PMID: 37943731

4

Upregulation of E-cadherin by the combination of methionine restriction and HDAC2 intervention for inhibiting gastric carcinoma metastasis.

Li Y, Liu C, Xin L, Liu C, Cao J, Yue Z, Sheng J, Yuan Y, Zhou Q, Liu Z. Li Y, et al. Acta Biochim Biophys Sin (Shanghai). 2024 Jan 25;56(1):62-70. doi: 10.3724/abbs.2023244. Acta Biochim Biophys Sin (Shanghai). 2024. PMID: 38143381 Free PMC article.

5

Construction of gastric cancer prognostic signature based on the E26 transcription factor and the identification of novel oncogene ELK3.

Liu C, Zhou L, Chen Z. Liu C, et al. Am J Cancer Res. 2024 Apr 15;14(4):1831-1849. doi: 10.62347/RVBP7871. eCollection 2024. Am J Cancer Res. 2024. PMID: 38726274 Free PMC article.

6

MiR-613 inhibits the proliferation, migration, and invasion of papillary thyroid carcinoma cells by directly targeting TAGLN2.

Huang Y, Zhang H, Wang L, Liu C, Guo M, Tan H, Liu Z. Huang Y, et al. Cancer Cell Int. 2021 Sep 16;21(1):494. doi: 10.1186/s12935-021-02083-8. Cancer Cell Int. 2021. PMID: 34530821 Free PMC article.

7

TAGLN2 promotes papillary thyroid carcinoma invasion via the Rap1/PI3K/AKT axis.

Wang L, Tan H, Huang Y, Guo M, Dong Y, Liu C, Zhao H, Liu Z. Wang L, et al. Endocr Relat Cancer. 2022 Dec 12;30(1):e210352. doi: 10.1530/ERC-21-0352. Print 2023 Jan 1. Endocr Relat Cancer. 2022. PMID: 36222755

8

Deltex3 inhibits Epithelial Mesenchymal Transition in Papillary Thyroid Carcinoma via promoting ubiquitination of XRCC5 to regulate the AKT signal pathway.

Wang L, Huang Y, Liu C, Guo M, Ma Z, He J, Wang A, Sun X, Liu Z. Wang L, et al. J Cancer. 2021 Jan 1;12(3):860-873. doi: 10.7150/jca.48141. eCollection 2021. J Cancer. 2021. PMID: 33403043 Free PMC article.

9

The chemokine receptor CXCR7 is a critical regulator for the tumorigenesis and development of papillary thyroid carcinoma by inducing angiogenesis in vitro and in vivo.

Zhang H, Yang L, Teng X, Liu Z, Liu C, Zhang L, Liu Z. Zhang H, et al. Tumour Biol. 2016 Feb;37(2):2415-23. doi: 10.1007/s13277-015-4051-5. Epub 2015 Sep 17. Tumour Biol. 2016. PMID: 26383519

10

iTRAQ-coupled 2D LC/MS-MS analysis of CXCR7-transfected papillary thyroid carcinoma cells: A new insight into CXCR7 regulation of papillary thyroid carcinoma progression and identification of potential biomarkers.

Zhang H, Yang L, Liu Z, Liu C, Teng X, Zhang L, Yin B, Liu Z. Zhang H, et al. Oncol Lett. 2017 Sep;14(3):3734-3740. doi: 10.3892/ol.2017.6574. Epub 2017 Jul 15. Oncol Lett. 2017. PMID: 28927140 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,046 results

Search Page

Filters